Trade Summary

11 months ago, Brackmann Christoph, serving as CFO at Novocure Ltd (NVCR), purchased 20,000 shares at $11.59 per share, for a total transaction value of $231,800.00. Following this transaction, Brackmann Christoph now holds 141,150 shares of NVCR.

This purchase represents a 17.00% increase in Brackmann Christoph's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, July 29, 2025 and publicly disclosed via SEC Form 4 filing on Wednesday, July 30, 2025 at 4:33 PM ET, 1 day after the trade was made.

Novocure Ltd operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.